YesAsia Holdings Limited (FRA:4CM)
Germany · Delayed Price · Currency is EUR 0.5100
-0.0050 (-0.97%)
Last updated: Jul 31, 2025
Intra-Cellular Therapies Revenue
In the year 2024, YesAsia Holdings had annual revenue of $345.78M USD with 71.74% growth. YesAsia Holdings had revenue of $182.43M in the half year ending December 31, 2024, with 177.73% growth.
Revenue
$345.78M
Revenue Growth
+71.74%
P/S Ratio
0.61
Revenue / Employee
$664.97K
Employees
520
Market Cap
204.61M
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 345.78M | 144.44M | 71.74% |
| Dec 31, 2023 | 201.34M | 72.75M | 56.57% |
| Dec 31, 2022 | 128.59M | -33.43M | -20.63% |
| Dec 31, 2021 | 162.02M | -11.30M | -6.52% |
| Dec 31, 2020 | 173.32M | 55.73M | 47.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.89B |
| Siemens Aktiengesellschaft | 77.82B |
| Deutsche Telekom AG | 120.25B |
| Allianz SE | 109.03B |
| Rheinmetall AG | 10.48B |
| Siemens Energy AG | 37.44B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
| Deutsche Bank Aktiengesellschaft | 30.07B |